Reuters logo
2 个月前
BRIEF-Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101
2017年6月14日 / 晚上8点26分 / 2 个月前

BRIEF-Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

June 14 (Reuters) - Avexis Inc:

* Avexis announces alignment with FDA on GMP commercial manufacturing process for AVXS-101

* Avexis Inc - Avexis anticipates initiating U.S. SMA Type 1 and Type 2 trials in Q3 2017 with product from new process

* Says ‍avexis will continue to utilize HEK293 cells and an adherent cell line​

* Says ‍alignment includes support for proposed commercial manufacturing process​

* Says ‍commercial-scale GMP process will not include use of hyperstacks for AAV9 vector production​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below